Editorial: Multidrug Resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues

Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance

(2014) Gergely Szakács et al.   CHEMICAL REVIEWS

ABC transporters in CSCs membranes as a novel target for treating tumor relapse

(2014) Laura Zinzi et al.   Frontiers in Pharmacology

Is redox signaling a feasible target for overcoming multidrug resistance in cancer chemotherapy?

(2014) Manuela Polimeni et al.   Frontiers in Pharmacology

Small and Innovative Molecules as New Strategy to Revert MDR

(2014) Laura Zinzi et al.   Frontiers in Oncology

Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function

(2014) Frances Jane Sharom   Frontiers in Oncology

In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies

(2014) Martina McDermott et al.   Frontiers in Oncology

Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?

(2013) João Conde et al.   Frontiers in Pharmacology

P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model

(2013) Chris E. Adkins et al.   Frontiers in Pharmacology

ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity

(2013) Charlotte Gauthier et al.   Frontiers in Pharmacology

Where is it and How Does it Get There – Intracellular Localization and Traffic of P-glycoprotein

(2013) Dong Fu   Frontiers in Oncology

Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression

(2011) Stefania Nobili et al.   MEDICINAL RESEARCH REVIEWS